Markets
CI

Cigna (CI) Q3 Earnings Beat as Revenues Rise, Tightens View

An image of a pen on a stock chart
Credit: Shutterstock photo

Cigna Corp . CI is the fifth largest managed care plan with a strong global supplemental business, Pharmacy Benefit Management (PBM) Services Agreement.

Its organizational efficiency plans as well as expansion of Seniors and Medicare business position it well for long run.

The company has a large international presence, which has kept it safe from reform.

The merger with Anthem Inc. would help Cigna (currently holding fourth rank) to leapfrog to the number one rank, in terms of membership in the U.S. health insurance industry, leaving behind UnitedHealth Group Inc. which currently holds the top position.

Cigna does have a decent history when it comes to earnings as the earnings has beaten estimates in all the last four reported quarters making for an average surprise of 5%.

Currently, Cigna has a Zacks Rank #3 (Hold), but that could definitely change following Cigna earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:

Earnings Beat : Cigna beat on earnings. Our consensus called for EPS of $2.18, and the company reported EPS of $2.28. EPS grew 11% year over year.

Revenue : Revenues of $9.4 billion surpassed the Zacks Consensus Estimate of $9.3 billion. Revenues also grew 7% year over year.

Key Stats to Note

Premiums of $7.3 billion increased 7.3% year over year. All the segments of the company - Global Health Care, Global Supplemental Benefits and Group Disability and Life - registered premium growth.

Total Medical Customers totaled 14.8 million as on Sep 30, 2015, up 3.5% year over year.

Cigna pulled up the lower end of its 2015 earnings guidance. It now expects income from operations in the range of $2.19 billion to $2.24 billion compared to the previous estimate of $ $2.16 billion to $2.24 billion. Earnings per share are expected in the range of $8.40 to $8.60 up from the previous range of $8.30 to $8.60 per share. It expects 9% revenue increase in 2015. The company expects global medical customer growth of 3%.

Check back later for our full write up on this Cigna earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CIGNA CORP (CI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CI

Other Topics

Earnings Investing Stocks

Latest Markets Videos